Reprogramming Myeloid Cells for Cancer: CAR-M from Ex Vivo to In Vivo

Time: 3:15 pm
day: Conference Day One


  • Targeting macrophages with CARs for solid tumors
  • Investigating pre-clinical and clinical data with ex vivo CAR-M cell therapies
  • Describing our in vivo CAR-M platform that is being developed in partnership with Moderna